Literature DB >> 22893217

Notice of withdrawal: A novel, orally active alpha 4 integrin antagonist, AJM300 prevents the development of experimental colitis induced by adoptive transfer of IL-10 deficient CD4+ T cells in mice.

.   

Abstract

Entities:  

Year:  2012        PMID: 22893217

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  1 in total

1.  First integrin inhibitor since Tysabri nears approval for IBD.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2014-03       Impact factor: 54.908

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.